Overview
Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg
Status:
Unknown status
Unknown status
Trial end date:
2011-12-01
2011-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The objective is evaluate, in healthy volunteers, the bioavailability of two products containing metformine 500 mg to determine if they are bioequivalent and identify the occurrence of adverse events.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
BiocineseTreatments:
Metformin
Criteria
Inclusion Criteria:- Within 10% of their ideal body weight
- Age between 18 and 50 years
- Healthy conditions
- Ability to understand the written informed consent
Exclusion Criteria:
- Pregnancy
- Smokers
- Alcohol and drugs